UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$456M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$403M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$391M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$381M |
| 5 |
UnitedHealth
UNH
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$3.79B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$596M |
| 4 |
Johnson & Johnson
JNJ
|
+$307M |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$256M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.25% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.58% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Bio-Techne
TECH
$11.2B
| $2.79M | ﹤0.01% |
34,221
+5,985
| +21% | +$481K |
|
3202
Remitly
RELY
$4.87B
| $2.79M | ﹤0.01% |
148,158
+107,781
| +267% | +$1.96M |
|
3203
Red Rock Resorts
RRR
$3.58B
| $2.78M | ﹤0.01% |
59,464
+15,212
| +34% | +$707K |
|
3204
PUT
Nutrien
NTR
$31.6B
| $2.78M | ﹤0.01% |
+47,100
| New | +$3M |
|
3205
PUT
AMC Entertainment Holdings
AMC
$2.16B
| $2.78M | ﹤0.01% |
63,210
-22,310
| -26% | -$1.1M |
|
|
IIF
3206
Morgan Stanley India Investment Fund
IIF
$220M
| $2.78M | ﹤0.01% |
128,304
+308
| +0.2% | +$6.24K |
|
|
JWN
3207
DELISTED
Nordstrom
JWN
| $2.78M | ﹤0.01% |
135,625
+48,557
| +56% | +$816K |
|
3208
CVR Energy
CVI
$3.26B
| $2.77M | ﹤0.01% |
92,587
-11,972
| -11% | -$322K |
|
3209
Hamilton Lane
HLNE
$5.53B
| $2.77M | ﹤0.01% |
34,667
+17,019
| +96% | +$1.22M |
|
3210
Xtrackers Russell US Multifactor ETF
DEUS
$305M
| $2.77M | ﹤0.01% |
61,735
+3,884
| +7% | +$167K |
|
3211
Liberty All-Star Equity Fund
USA
$1.86B
| $2.77M | ﹤0.01% |
428,378
+57,906
| +16% | +$354K |
|
3212
Medpace
MEDP
$16.8B
| $2.77M | ﹤0.01% |
11,514
+402
| +4% | +$83.5K |
|
|
MRO
3213
CALL
DELISTED
Marathon Oil Corporation
MRO
| $2.76M | ﹤0.01% |
+120,000
| New | +$2.83M |
|
3214
Genmab
GMAB
$19.2B
| $2.76M | ﹤0.01% |
72,622
+7,418
| +11% | +$296K |
|
3215
Atour Lifestyle Holdings
ATAT
$4.85B
| $2.76M | ﹤0.01% |
169,820
-181,264
| -52% | -$3.52M |
|
3216
Penumbra
PEN
$12.8B
| $2.75M | ﹤0.01% |
8,006
-707
| -8% | -$217K |
|
3217
Prestige Consumer Healthcare
PBH
$2.51B
| $2.75M | ﹤0.01% |
46,313
+15,685
| +51% | +$939K |
|
3218
PUT
The Mosaic Company
MOS
$7.46B
| $2.75M | ﹤0.01% |
78,600
-11,400
| -13% | -$441K |
|
3219
Samsara
IOT
$23.2B
| $2.75M | ﹤0.01% |
99,144
+72,091
| +266% | +$1.6M |
|
|
AJRD
3220
CALL
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $2.74M | ﹤0.01% |
+50,000
| New | +$2.78M |
|
3221
BWX Technologies
BWXT
$15.5B
| $2.74M | ﹤0.01% |
38,272
-5,840
| -13% | -$382K |
|
3222
Rocket Lab Corp
RKLB
$50B
| $2.73M | ﹤0.01% |
455,545
+383,354
| +531% | +$1.76M |
|
3223
Progress Software
PRGS
$1.78B
| $2.73M | ﹤0.01% |
46,918
+14,295
| +44% | +$812K |
|
3224
Ziff Davis
ZD
$2B
| $2.73M | ﹤0.01% |
38,902
+6,633
| +21% | +$454K |
|
|
LGI
3225
Lazard Global Total Return & Income Fund
LGI
$240M
| $2.72M | ﹤0.01% |
174,335
+408
| +0.2% | +$6.12K |
|
Similar funds
UBS Group's Q2 2023 Portfolio in Review
As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
- UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
- UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
- UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
- UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
- UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
- UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.